Dual listing of Wellnex on the London Stock Exchange to provide acceleration of our international expansion Investment highlights
▪ Wellnex has commenced the process to dual list on the London Stock Exchange that will provide a pathway to accelerate our growth both domestically and internationally.
▪ Wellnex has appointed UK based Strand Hanson as Financial Advisor for the dual listing on the London Stock Exchange.
▪ Barclay Pearce Capital and UK based Orana Corporation have been appointed as joint-lead brokers for the dual listing.
▪ Wellnex listing on the London Stock Exchange will capitalise on our international growth on the back of:
o Haleon taking our products to the Middle East and European markets.
o Homart Pharmaceuticals distributing our brands throughout Asia.
▪ Dual listing provides greater exposure to a larger pool of institutional cinvestors.
